1
|
Světlák M, Malatincová T, Halámková J, Barešová Z, Lekárová M, Vigašová D, Slezáčková A, Šumec R, Humpolíček P, Šedo J, Chládek J, Roman R, Gottwaldová J, Gescheidtová L, Čermáková Z, Thon V, Hrnčiříková I, Kazda T, Svoboda M. The effectiveness of three mobile-based psychological interventions in reducing psychological distress and preventing stress-related changes in the psycho-neuro-endocrine-immune network in breast cancer survivors: Study protocol for a randomised controlled trial. Internet Interv 2023; 32:100628. [PMID: 37273931 PMCID: PMC10235427 DOI: 10.1016/j.invent.2023.100628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/10/2023] [Revised: 04/16/2023] [Accepted: 05/04/2023] [Indexed: 06/06/2023] Open
Abstract
Background A growing body of literature shows that psychological distress is not only a major threat to psychological well-being but can also have a significant impact on physical health. In cancer patients, it can negatively affect prognosis and posttreatment recovery processes. Since face-to-face psychological interventions are often inaccessible to cancer patients, researchers have recently been focusing on the effectiveness of eHealth adaptations of well-established approaches. In this context, there has been a call for high-quality randomised controlled trials that would allow for a direct comparison of different approaches, potentially addressing different needs and preferences of patients, and also for more systematic research focusing on how psychological interventions affect not only psychological but also biological markers of stress. Both of these questions are addressed in the present study. Methods A randomised controlled trial will be carried out to test and compare the effectiveness of three eight-week eHealth programmes for the mental health support of cancer patients. All programmes will be delivered through the same application for mobile devices MOU MindCare. N = 440 of breast cancer survivors will be recruited at the end of their adjuvant treatment (chemotherapy, radiotherapy, or both) and randomly assigned to one of the three interventions - Mindfulness-Based Cognitive Therapy for Cancer (MBCT-Ca), Positive Psychology (PP), or Autogenic Training (AT) - or the treatment-as-usual (TAU) control group. Psychological and biological markers of stress and adaptive functioning will be assessed at baseline (T0), post-treatment (T1), three-month follow-up (T2), and nine-month follow-up (T3). Primary outcomes will include heart-rate variability and self-report measures of depression, anxiety, perceived stress, general quality of life, and positive mental health. Secondary outcomes will include the levels of serum cortisol and immunomarkers, sleep quality, fatigue, common health symptoms, and several transdiagnostic psychological variables that are expected to be specifically affected by the MBCT-Ca and PP interventions, including dispositional mindfulness, emotion regulation, self-compassion, perceived hope, and gratitude. The data will be analysed using the mixed model repeated measures (MMRM) approach. Discussion This trial is unique in comparing three different eHealth interventions for cancer patients based on three well-established approaches to mental health support delivered on the same platform. The study will allow us to examine whether different types of interventions affect different indicators of mental health. In addition, it will provide valuable data regarding the effects of stress-reducing psychological interventions on the biomarkers of stress playing an essential role in cancer recovery processes and general health.
Collapse
Affiliation(s)
- Miroslav Světlák
- Department of Medical Psychology and Psychosomatics, Faculty of Medicine, Masaryk University, Kamenice 5, 63900 Brno, Czech Republic
- Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Žlutý Kopec 7, 65653 Brno, Czech Republic
| | - Tatiana Malatincová
- Department of Medical Psychology and Psychosomatics, Faculty of Medicine, Masaryk University, Kamenice 5, 63900 Brno, Czech Republic
| | - Jana Halámková
- Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Žlutý Kopec 7, 65653 Brno, Czech Republic
| | - Zdeňka Barešová
- Department of Medical Psychology and Psychosomatics, Faculty of Medicine, Masaryk University, Kamenice 5, 63900 Brno, Czech Republic
| | - Monika Lekárová
- Department of Medical Psychology and Psychosomatics, Faculty of Medicine, Masaryk University, Kamenice 5, 63900 Brno, Czech Republic
| | - Dana Vigašová
- Department of Medical Psychology and Psychosomatics, Faculty of Medicine, Masaryk University, Kamenice 5, 63900 Brno, Czech Republic
| | - Alena Slezáčková
- Department of Medical Psychology and Psychosomatics, Faculty of Medicine, Masaryk University, Kamenice 5, 63900 Brno, Czech Republic
| | - Rastislav Šumec
- Department of Medical Psychology and Psychosomatics, Faculty of Medicine, Masaryk University, Kamenice 5, 63900 Brno, Czech Republic
- The First Department of Neurology, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Pekařská 53, 60500 Brno, Czech Republic
| | - Pavel Humpolíček
- Department of Medical Psychology and Psychosomatics, Faculty of Medicine, Masaryk University, Kamenice 5, 63900 Brno, Czech Republic
| | - Jiří Šedo
- Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Žlutý Kopec 7, 65653 Brno, Czech Republic
| | - Jan Chládek
- The First Department of Neurology, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Pekařská 53, 60500 Brno, Czech Republic
- Institute of Scientific Instruments, The Czech Academy of Sciences, Královopolská 147, 61264 Brno, Czech Republic
- Behavioural and Social Neuroscience Research Group, CEITEC–Central European Institute of Technology, Masaryk University, Kamenice 5, 63900 Brno, Czech Republic
| | - Robert Roman
- Department of Medical Psychology and Psychosomatics, Faculty of Medicine, Masaryk University, Kamenice 5, 63900 Brno, Czech Republic
- Behavioural and Social Neuroscience Research Group, CEITEC–Central European Institute of Technology, Masaryk University, Kamenice 5, 63900 Brno, Czech Republic
- Department of Psychiatry, Faculty of Medicine, Masaryk University, Jihlavská 20, 62500 Brno, Czech Republic
| | - Jana Gottwaldová
- Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Žlutý Kopec 7, 65653 Brno, Czech Republic
| | - Lenka Gescheidtová
- Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Žlutý Kopec 7, 65653 Brno, Czech Republic
| | - Zdeňka Čermáková
- Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Žlutý Kopec 7, 65653 Brno, Czech Republic
| | - Vojtěch Thon
- Department of Studies Design and Data Management, RECETOX, Faculty of Science, Masaryk University, Kamenice 34, 62500 Brno, Czech Republic
| | - Iva Hrnčiříková
- Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Žlutý Kopec 7, 65653 Brno, Czech Republic
| | - Tomáš Kazda
- Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Žlutý Kopec 7, 65653 Brno, Czech Republic
| | - Marek Svoboda
- Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Žlutý Kopec 7, 65653 Brno, Czech Republic
| |
Collapse
|